Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 2: Smoke chemistry and in vitro toxicological evaluation using smoking regimens reflecting human puffing behavior

Regulatory Toxicology and Pharmacology

Volumn 64, Issue SUPPL. 2, 2012, Pages

  Zenzen, Volker ^a   Diekmann, Joerg ^a   Gerstenberg, Birgit ^a   Weber, Susanne ^a   Wittke, Sandra ^a   Schorp, Matthias K ^b  

^a Philip Morris Research Laboratories GmbH   (Germany)

^b PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Cytotoxicity; EHCSS; Harmful and potentially harmful constituent; HPHC; Human puffing behavior; In vitro; Mainstream Smoke; Mutagenicity; Smoke chemistry; Smoking regimen; Toxicological evaluation

Indexed keywords

ALDEHYDE; ALKADIENE; AMINE; AROMATIC AMINE; AROMATIC COMPOUND; CARBON MONOXIDE; GLYCERYL TRINITRATE; INORGANIC COMPOUND; METAL; NEUTRAL RED; NICOTINE; NITROSAMINE; PHENOL DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; TAR; TOXIC SUBSTANCE; WATER;

AMES TEST; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY TEST; ELECTRICAL EQUIPMENT; ELECTRICALLY HEATED CIGARETTE SMOKING SYSTEM; IN VITRO STUDY; MUTAGENICITY; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SMOKING; SMOKING HABIT;

ANIMALS; BALB 3T3 CELLS; BEHAVIOR; BIOLOGICAL MARKERS; CARBON MONOXIDE; CELL SURVIVAL; DATA INTERPRETATION, STATISTICAL; ELECTRICITY; HOT TEMPERATURE; HUMANS; INHALATION EXPOSURE; MICE; MODELS, PSYCHOLOGICAL; MUTAGENICITY TESTS; NICOTINE; SALMONELLA TYPHIMURIUM; SMOKING; TARS; TOBACCO; TOBACCO PRODUCTS; TOBACCO SMOKE POLLUTION;

BACTERIA (MICROORGANISMS); SALMONELLA TYPHIMURIUM;

EID: 84868365388     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.08.004     Document Type: Article

References (96)

1. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 1975, 31:347-363.
2. Andreoli C., Gigante D., Nunziata A. A review of in vitro assays to assess the biological activity of cigarette smoke with the aim of reducing the toxicity of smoke. Toxicol. In Vitro 2003, 17:587-594.
3. Babich H., Borenfreund E. Cytotoxic and morphological effects of phenylpropanolamine, caffeine, nicotine, and some of their metabolites studied in vitro. Toxicol. In Vitro 1992, 6:493-502.
4. Baker R.R., Proctor C.J. Where there's smoke. Chem. Br. 2001, 37:38-41.
5. Bobak M., Jarvis M.J., Skodova Z., Marmot M. Smoke intake among smokers is higher in lower socioeconomic groups. Tob. Control 2000, 9:310-312.
6. Bombick D.W., Putnam K., Doolittle D.J. Comparative cytotoxicity studies of smoke condensates from different types of cigarettes and tobaccos. Toxicol. In Vitro 1998, 12:241-249.
7. Borenfreund E., Babich H., Martin-Alguacil N. Comparison of two in vitro cytotoxicity assays. The neutral red (NR) and tetrazolium MTT tests. Toxicol. In Vitro 1988, 2:1-6.
8. Borenfreund E., Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 1985, 24:119-124.
9. Bridges R.B., Combs J.G., Humble J.W., Turbek J.A., Rehm S.R., Haley N.J. Population characteristics and cigarette yields as determinants of smoke exposure. Pharmacol. Biochem. Behav. 1990, 37:17-28.
10. Bridges R.B., Combs J.G., Humble J.W., Turbek J.A., Rehm S.R., Haley H.J. Puffing topography as determinant of smoke exposure. Pharmacol. Biochem. Behav. 1990, 37:29-39.
11. Bridges R.B., Humble J.W., Turbek J.A., Rehm S.R. Smoking history, cigarette yield, and smoking behavior as determinants of smoke exposure. Eur. J. Respir. Dis. Suppl. 1986, 146:129-137.
12. Burns, D.M., 2006. Experience ISO machine measurements of cigarette yields. In: Technical Briefing; Conference of the Parties (COP1): Geneva, 7 February 2006.
13. Burns D.M., Dybing E., Gray N., Hecht S., Anderson C., Sanner T., O'Connor R., Djordjevic M., Dresler C., Hainaut P., Jarvis M., Opperhuizen A., Straif K. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob. Control 2008, 17:132-141.
14. Byrd G.D., Fowler K.W., Hicks R.D., Lovette M.E., Borgerding M.F. Isotope dilution gas chromatography-mass spectrometry in the determination of benzene, toluene, styrene, and acrylonitrile in mainstream cigarette smoke. J. Chromatogr. 1990, 503:359-368.
15. Counts M.E., Hsu F.S., Laffoon S.W., Dwyer R.W., Cox R.H. Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regul. Toxicol. Pharmacol. 2004, 39:111-134.
16. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutat. Res. 1983, 114:59-89.
17. Deyton L., Sharfstein J., Hamburg M. Tobacco product regulation: A public health approach. NEJM 2010, 362:1753-1756.
18. Eberhardt H.J., Scherer G. Human smoking behavior in comparison with machine smoking methods: A summary of five papers presented at the 1995 meeting of the CORESTA Smoke and Technology groups in Vienna. Beitr. Tabakforsch. Int. 1995, 16:131-140.
19. European Communities, 2001. Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the approximation of the laws, regulations, and administrative provisions of the Member States concerning the manufacture, presentation, and sale of tobacco products. Off. J. Eur. Commun. L 194/26.
20. Family Smoking Prevention and Tobacco Control Act (FSPTCA), 2009. Public Law No. 111-31 (June 22, 2009).
21. Federal Trade Commission, 2008. FTC rescinds guidance from 1966 on statements concerning tar and nicotine yields. Available from: (accessed 14.12.2009). http://www.ftc.gov/opa/2008/11/cigarettetesting.shtm.
22. Feng S., Roethig H.J., Liang Q., Kinser R., Jin Y., Scherer G., Urban M., Engl J., Riedel K. Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans, trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2'-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 2006, 11:28-52.
23. Fischer S., Spiegelhalder B., Preussmann R. Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke - A contribution to relative risk evaluation. Carcinogenesis 1989, 10:1059-1066.
24. Food and Drug Administration, 2012. FDA's Guidance for Industry " Modified Risk Tobacco Products Applications" Request for Comments Docket No. FDA-2012-D-0071. Available from: (accessed 23.05.2012). http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297750.htm.
25. Frost-Pineda K., Zedler B.K., Liang Q., Roethig H.J. Environmental tobacco smoke (ETS) evaluation of a third-generation electrically heated cigarette smoking system (EHCSS). Regul. Toxicol. Pharmacol. 2008, 52:118-121.
26. Frost-Pineda K., Zedler B.K., Oliveri D., Feng S., Liang Q., Roethig H.J. Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul. Toxicol. Pharmacol. 2008, 52:104-110.
27. Frost-Pineda K., Zedler B.K., Oliveri D., Liang Q., Feng S., Roethig H.J. 12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul. Toxicol. Pharmacol. 2008, 52:111-117.
28. Good Laboratory Practice Principles of Gemany (GLP), 1994. Grundsaetze der guten Laborpraxis (GLP), Chemikaliengesetz, 25.Jul.1994. Bundesgesetzblatt I.
29. Gori G.B., Lynch C.J. Analytical cigarette yields as predictors of smoke bioavailibility. Regul. Toxicol. Pharmacol. 1985, 5:314-326.
30. Hakura A., Shimada H., Nakajima M., Sui H., Kitamoto S., Suzuki S., Satoh T. Salmonella/human S9 mutagenicity test: A collaborative study with 58 compounds. Mutagenesis 2005, 20:217-228.
31. Health Canada, 1999. Determination of " tar", Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke - Official Method, Ottawa. Available from: (accessed 27.09.2011). http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/legislation/reg/indust/method/_main-principal/nicotine-eng.php.
32. Hsu, F.S., Yang, S.S., Johnson, L.P., Smetana, I., 1999. Analysis of formaldehyde, acetaldehyde, acrolein in mainstream and sidestream smoke. In: 53rd Tobacco Chemists' Research Conference, Montreal, Canada, 27-30 September 1999.
33. Scientific Standards for Studies on Modified Risk Tobacco Products 2012, Institute of Medicine, The National Academy Press, Washington, DC.
34. Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans - Tobacco Smoking 1986, vol. 38. International Agency for Research on Cancer, IARC, Lyon.
35. International Conference on Harmonization, 1995. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. ICH Harmonized Tripatite Guideline: Guideline on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals S2A. Geneva, Switzerland, IFPMA.
36. International Conference on Harmonization, 1996. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. ICH Harmonized Tripartite Guideline: Validation of Analytical Procedures: Methodology Q2B. Geneva, Switzerland, IFPMA.
37. International Organization for Standardization, 1991. Tobacco and Tobacco Products - Atmosphere for Conditioning and Testing. ISO 3402. Geneva, International Organization for Standardization.
38. International Organization for Standardization, 1995a. Cigarettes - Determination of water in Smoke Condensates - Part 2: Karl Fischer Method. ISO 10362-2, Geneva, International Organization for Standardization.
39. Cigarettes - Determination of Carbon Monoxide in the Vapour Phase of Cigarette Smoke - NDIR Method. ISO 8454 1995, International Organization for Standardization, International Organization for Standardization, Geneva. second ed.
40. Routine Analytical Cigarette-Smoking Machine - Definitions and Standard Conditions. Standard 3308 2000, International Organization for Standardization, International Organization for Standardization, Geneva. fourth ed.
41. Cigarettes - Determination of Total and Nicotine-Free Dry Particulate Matter Using a Routine Analytical Smoking Machine. ISO Standard 4387 2000, International Organization for Standardization, International Organization of Standardization, Geneva. third ed.
42. Cigarettes - Determination of Nicotine in Smoke Condensates - Gas Chromatographic Method. ISO Standard 10315 2000, International Organization for Standardization, International Organization for Standardization, Geneva. second ed.
43. INVITTOX, 1990. Protocol No. 3a: The FRAME modified neutral red uptake cytotoxicity test. In: The ERGATT/FRAME Data Bank of In Vitro Techniques in Toxicology. INVITTOX, Nottingham.
44. The Reference Cigarette 2003, Kentucky Tobacco Research and Development Center, University of Kentucky Printing Services, Lexington, Kentucky.
45. Kolonen S., Tuomisto J., Puustinen P., Airaksinen M.M. Smoking behavior in low-yield cigarette smokers and switchers in the natural environment. Pharmacol. Biochem. Behav. 1991, 40:177-180.
46. Laugesen M., Fowles J. Marlboro UltraSmooth: A potentially reduced exposure cigarette?. Tob. Control 2006, 15:430-435.
47. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
48. Martin Leroy C., Jarus-Dziedzic K., Ancerewicz J., Lindner D., Kulesza A., Magnette J. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S74-S84.
49. Mizobuchi M., Tamase K., Kitada Y., Sasaki M., Tanigawa K. Liquid chromatographic determination of ammonium in water. Anal. Chem. 1984, 56:603-605.
50. Moennikes O., Vanscheeuwijck P.M., Friedrichs B., Anskeit E., Patskan G.J. Reduced toxicological activity of cigarette smoke by the addition of ammonia magnesium phosphate to the paper of an electrically heated cigarette: Subchronic inhalation toxicology. Inhal. Toxicol. 2008, 20:647-663.
51. Moody P.M. The relationships of quantified human smoking behavior and demographic variables. Soc. Sci. Med. 1980, 14A:49-54.
52. Nanni E.J., Lovette M.E., Hicks R.D., Fowler K.W., Borgerding M.F. Separation and quantitation of phenolic compounds in mainstream cigarette smoke by capillary gas chromatography with mass spectrometry in the selected-ion mode. J. Chromatogr. 1990, 505:365-374.
53. National Institute of Health, 2001. Report of the international workshop on in vitro methods for assessing acute systemic toxicity. NIH Publication No. 01-4499. Research Triangle Park, N.C., National, Toxicology Program (NTP).
54. Nil R., Baettig K. Separate effects of cigarette smoke yield and smoke taste on smoking behavior. Psychopharmacology (Berl.) 1989, 99:54-59.
55. Oey, J., Kinser, R.D., Feng, S., Nelson, B.L., Liang, Q., Roethig, H.J., 2003. Clinical exposure evaluation of a new electrically heated cigarette smoking system. J. Clin. Pharmacol. 43, 1029. In: 32nd Annual Meeting of the American College of Clinical Pharmacology, Tampa, FL, September 21-23, 2003.
56. Organization for Economic Co-operation and Development, 1987. Good Laboratory Practice Regulations for Non-clinical Studies (GLP). OECD.
57. Organization for Economic Co-operation and Development, 1997. Bacterial reverse mutation test. In: OECD Guidelines for Testing of Chemicals. OECD, Paris.
58. Patskan G., Reininghaus W. Toxicological evaluation of an electrically heated cigarette. Part 1: Overview of technical concepts and summary of findings. J. Appl. Toxicol. 2003, 23:323-328.
59. Putnam K.P., Bombick D.W., Doolittle D.J. Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate. Toxicol. In Vitro 2002, 16:599-607.
60. Roemer E., Meisgen T.J., Tewes F.J., Solana R.P. Discrimination of cigarette mainstream smoke condensates with the Salmonella reverse mutation assay. The Toxicologist 1998, 42(1-S):295.
61. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R.A., Gaworski C.L., Podraza K.F. Chemical composition, cytotoxicity, and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 2004, 195:31-52.
62. Roemer E., Stabbert R., Veltel D., Mueller B.P., Meisgen T.J., Schramke H., Anskeit E., Elves R.G., Fournier J.A. Reduced toxicological activity of cigarette smoke by the addition of ammonium magnesium phosphate to the paper of an electrically heated cigarette: Smoke chemistry and in vitro cytotoxicity and genotoxicity. Toxicol. In Vitro 2008, 22:671-681.
63. Roemer E., Tewes F.J., Meisgen T.J., Veltel D.J., Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 3: In vitro genotoxicity and cytotoxicity. Food Chem. Toxicol. 2002, 40:105-111.
64. Roethig H.J., Feng S., Liang Q., Liu J., Rees W.A., Zedler B.K. A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 2008, 48:580-591.
65. Roethig H.J., Kinser R.D., Lau R.W., Walk R.A., Wang N. Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. J. Clin. Pharmacol. 2005, 45:133-145.
66. Roethig H.J., Kinser R.D., Nelson B.L., Oey J., Wang N. Short-term clinical exposure evaluation of conventional and electrically heated cigarettes. J. Clin. Pharmacol. 2002, 42:1065.
67. Roethig H.J., Zedler B.K., Kinser R.D., Feng S., Nelson B.L., Liang Q. Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 2007, 47:518-530.
68. Rustemeier K., Patskan G., Hausmann H.J. The influence of a modified puffing regimen on the yields of smoke constituents from electrically heated and conventional research cigarettes. Toxicol. Sci. 2000, 54(Suppl.1):16.
69. Scherer G. Smoking behavior and compensation: A review of the literature. Psychopharmacology (Berl.) 1999, 145:1-20.
70. Schorp, M.K., Tricker, A.R., Dempsey, R., 2012. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 1: Non-clinical and clinical testing strategy. Regul. Toxicol. Pharmacol. In this supplement, more details to be added as available.
71. Schramke H., Meisgen T.J., Tewes F.J., Gomm W., Roemer E. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 2006, 227:193-210.
72. Stabbert R., Voncken P., Rustemeier K., Hausmann H.J., Roemer E., Schaffernicht H., Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 2: Chemical composition of mainstream smoke. J. Appl. Toxicol. 2003, 23:329-339.
73. Stabbert R., Schaefer K.H., Biefel C., Rustemeier K. Analysis of aromatic amines in cigarette smoke. Rapid Commun. Mass Spectrom. 2003, 17:2125-2132.
74. Terpstra P.M., Teredesai A., Vanscheeuwijck P.M., Verbeeck J., Schepers G., Radtke F., Kuhl P., Gomm W., Anskeit E., Patskan G. Toxicological evaluation of an electrically heated cigarette: Part 4: Subchronic inhalation toxicology. J. Appl. Toxicol. 2003, 23:349-362.
75. Tewes F.J., Meisgen T.J., Veltel D.J., Roemer E., Patskan G. Toxicological evaluation of an electrically heated cigarette: Part 3: Genotoxicity and cytotoxicity of mainstream smoke. J. Appl. Toxicol. 2003, 23:341-348.
76. Tewes F.J., Meisgen T.J., Gomm W.A., Roemer E., Carchman R.A. Cigarette parameters that influence the mutagenicity of mainstream smoke condensate. The Toxicologist 1999, 48(1-S):296.
77. Torikai K., Uwano Y., Nakamori T., Tarora W., Takahashi H. Study on tobacco components involved in the pyrolytic generation of selected smoke constituents. Food Chem. Toxicol. 2005, 43:559-568.
78. Tricker A.R., Stewart A.J., Martin Leroy C., Lindner D., Schorp M.K., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: 8-day randomized clinical trial in the U.K. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S35-S44.
79. Tricker A.R., Jang I.-J., Martin Leroy C., Lindner D., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: 8-day randomized clinical trial in Korea. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S45-S53.
80. Tricker A.R., Kanada S., Takada K., Martin Leroy C., Lindner D., Schorp M.K., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-day randomized clinical trial in Japan. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S54-S63.
81. Tricker A.R., Lindner D., Martin Leroy C., Schorp M.K., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-day randomized clinical trial of a menthol cigarette in Japan. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S64-S73.
82. Tricker A.R., Schorp M.K., Urban H.-J., Leyden D., Hagedorn H.W., Engl J., Urban M., Riedel K., Gilch G., Janket D., Scherer G. Comparison of environmental tobacco smoke (ETS) concentrations generated by an electrically heated cigarette smoking system and a conventional cigarette. Inhal. Toxicol. 2009, 21:62-77.
83. Unverdorben M., van der Bijl A., Potgieter L., Liang Q., Meyer B.H., Roethig H.J. Effects of levels of cigarette smoke exposure on symptom-limited spiroergometry. Prev. Cardiol. 2007, 10:83-91.
84. Unverdorben M., van der Bijl A., Potgieter L., Liang Q., Roethig H.J. A randomized, controlled, crossover study assessing the exercise performance in adult smokers comparing electrically heated cigarettes, conventional cigarettes, and no-smoking. Clin. Pharmacol. 2005, 45:1069.
85. Unverdorben M., van der Bijl A., Potgieter L., Liang Q., Roethig H.J. Heart rate and blood pressure recording in comparing a conventional cigarette to an electrically heated cigarette smoking system and no-smoking. Clin. Pharmacol. 2005, 45:1084.
86. Unverdorben M., van der Bijl A., Potgieter L., Venter C., Munjal S., Liang Q., Meyer B., Roethig H.J. Effects of different levels of cigarette smoke exposure on prognostic heart rate and rate - Pressure-product parameters. J. Cardiovasc. Pharmacol. Ther. 2008, 13:175-182.
87. Urban H.-J., Gomm W., Schorp M. A modelling approach to develop machine smoking protocols reflecting human puffing behaviour for conventional cigarettes. Beitr. Tabakforsch. Intl. 2008, 23:8-18.
88. Urban H.-J., Tricker A.R., Leyden D.E., Forte N., Zenzen V., Feuersenger A., Assink M., Kallischnigg G., Schorp M.K. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 8: Nicotine Bridging - Estimating smoke constituent exposure by their relationships to both nicotine levels in mainstream smoke and in smokers. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S85-S97.
89. US Consumer Product Safety Commission (CPSC) in Consultation with the U.S. Department of Health and Human Services, 1993. Toxicity Plan 5. US Consumer Product Safety Commission.
90. Wagner K.A., Finkel N.H., Fossett J.E., Gillman I.G. Development of a quantitative method for the analysis of tobacco-specific nitrosamines in mainstream cigarette smoke using isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Chem. 2005, 77:1001-1006.
91. Weber S., Meisgen T.J., Diekmann J., Wittig A., Rustemeier K. Contribution of single smoke constituents to the mutagenic activity of the gas/vapor phase of cigarette mainstream smoke. Toxicol. Sci. 2010, 114:149.
92. Werley M.S., Freelin S.A., Wrenn S.E., Gerstenberg B., Roemer E., Schramke H., Miert E.V., Vanscheeuwijck P., Weber S., Coggins C.R.E. Smoke chemistry, in vitro and in vivo toxicology evaluations of the Electrically Heated Cigarette Smoking System Series K. Regul. Toxicol. Pharmacol. 2008, 52:122-139.
93. WHO Study Group on Tobacco Product Regulation, 2007. The scientific basis of tobacco product regulation. WHO Technical Report Series 945, Geneva.
94. WHO Study Group on Tobacco Product Regulation, 2008. The scientific basis of tobacco product regulation. WHO Technical Report Series 951, Geneva.
95. Woodman G., Newman S.P., Pavia D., Clarke S.W. Response and acclimatisation of symptomless smokers on changing to a low tar, low nicotine cigarette. Thorax 1987, 42:336-341.
96. Zacny J.P., Stitzer M.L. Cigarette brand-switching: Effects on smoke exposure and smoking behavior. J. Pharmacol. Exp. Ther. 1988, 246:619-627.